Mike McGaugh
Analyst · KeyBanc Capital Markets.
Yes, for sure, Steve. The training is in process. We’ve got approximately 60 salespeople. We’re about third through with that training. It’s actually – it’s not a 1 day training. It’s actually a month-long process. It’s very robust. I used it at a prior company. It was very effective. So I’d say, Steve, we’re probably 30% complete, give or take, on the training and development. But part of it also is we just launched what we call Myers University, which is an in-house employee development tool designed to, really, to attract and retain all functions in all of our employees, both labor-oriented and professional. And so this will fold into – the commercial excellence piece will ultimately fold into Myers University. A lot of it is the standardizations of roles, moving away from the OpCo approach that we’ve had for the last 5 years and moving into a consolidated approach, where we have standardized roles on market management, product management, asset management, sales, sales management for Myers, particularly separating material handling from distribution. There is probably I’d say 8 to 10 meaningful cross-selling opportunities. I don’t know if I specifically want to mention the names. But there are several accounts where often, we’re seeing it that they are rotational molding account that also purchases blow molded or thermoformed product. And because of supply issues, we’re actually seeing some of our competitors in the market, some of the smaller converters having supply interruptions from the resin side. And we’ve been able to step in – or they have supply interruptions because of labor. And we’ve been able to step in and pick up business with a high quality from a product standpoint and a high service level and we are not having to buy the business. And those customers are indicating they are going to stay with us, particularly after we’ve gotten them through a tough spot. There is probably 8 to 10 of those examples, totaling $10 million to $15 million on an annualized basis. That’s part of what we’re seeing on the positive outlook. This cross-selling is playing a big role there. The other piece is just having senior managers and sales directors that have a very regimented approach to how they go-to-market. That’s a big change. We’re seeing that on the injection molding side, particularly with Buckhorn, also with Akro. That’s where a lot of the demand is coming back. And it’s because of a more concerted, I’d say, professional and regimented approach to sales.